New Zealand markets close in 5 hours 18 minutes

Bio-Rad Laboratories, Inc. (BIO)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
476.94+7.25 (+1.54%)
At close: 04:04PM EST
476.94 +0.29 (+0.06%)
After hours: 04:04PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 13.77B
Enterprise value 13.30B
Trailing P/E N/A
Forward P/E 31.35
PEG ratio (5-yr expected) 1.07
Price/sales (ttm)5.05
Price/book (mrq)1.67
Enterprise value/revenue 4.74
Enterprise value/EBITDA -1.73

Trading information

Stock price history

Beta (5Y monthly) 0.90
52-week change 3-23.95%
S&P500 52-week change 3-9.08%
52-week high 3670.62
52-week low 3344.63
50-day moving average 3432.62
200-day moving average 3465.65

Share statistics

Avg vol (3-month) 3181.33k
Avg vol (10-day) 3144.15k
Shares outstanding 524.75M
Implied shares outstanding 6N/A
Float 821.33M
% held by insiders 114.40%
% held by institutions 180.13%
Shares short (12 Jan 2023) 4278.07k
Short ratio (12 Jan 2023) 41.72
Short % of float (12 Jan 2023) 41.31%
Short % of shares outstanding (12 Jan 2023) 40.93%
Shares short (prior month 14 Dec 2022) 4232.11k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 307 Mar 2002

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022

Profitability

Profit margin -215.16%
Operating margin (ttm)19.08%

Management effectiveness

Return on assets (ttm)2.09%
Return on equity (ttm)-50.74%

Income statement

Revenue (ttm)2.8B
Revenue per share (ttm)93.98
Quarterly revenue growth (yoy)-8.90%
Gross profit (ttm)1.67B
EBITDA 666.12M
Net income avi to common (ttm)-6.03B
Diluted EPS (ttm)-3.39
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.85B
Total cash per share (mrq)62.03
Total debt (mrq)1.38B
Total debt/equity (mrq)16.31
Current ratio (mrq)5.50
Book value per share (mrq)283.45

Cash flow statement

Operating cash flow (ttm)261.95M
Levered free cash flow (ttm)199.06M